Mucosal tumor vaccination delivering endogenous tumor antigens protects against pulmonary breast cancer metastases.

In summary, our study demonstrates that mucosal vaccination is a promising strategy to harness the power of antitumor TRM and its potential combination with state-of-the-art treatments.